In life, there is nothing to be afraid of, only many things to learn
Marie Curie
RESEARCH AND THERAPY FOR NEOPLASTIC HEMATOLOGIC DISORDERS

data center

Our Data Center is structured in five different offices that collaborate closely in order to attain the Foundation’s purposes

read more >
clinical trials

A clinical trial is an experimentation on human subjects intended to identify or verify the clinical outcomes of one or more experimental drugs

read more >
cooperation

In the research field, success is obtained through joint effort and tight collaboration among scientific institutions and groups involved in comparing their own experiences

read more >
WHO WE ARE

FO.NE.SA. ONLUS (Fondazione Neoplasie Sangue) is a non-profit foundation, wich fosters and finances scientific research while economically supporting patients and their families. Hematologic pathologies are the main field of activity, with close attention to multiple myeloma. For more than a decade, FO.NE.SA. has been a touchstone for physicians, researchers, and experts in the field who are involved in the study of this type of pathologies. The Foundation also supports whoever has to face long paths of therapy and recovery.

read more >

Prof. Mario Boccadoro
President of FO.NE.SA. ONLUS
and his collaborators

WHO WE ARE

Prof. Mario Boccadoro
President of FO.NE.SA. ONLUS
and his collaborators

FO.NE.SA. ONLUS (Fondazione Neoplasie Sangue) is a non-profit foundation, wich fosters and finances scientific research while economically supporting patients and their families. Hematologic pathologies are the main field of activity, with close attention to multiple myeloma. For more than a decade, FO.NE.SA. has been a touchstone for physicians, researchers, and experts in the field who are involved in the study of this type of pathologies. The Foundation also supports whoever has to face long paths of therapy and recovery.

read more >
OBJECTIVES ACHIEVED
34

New
therapy protocols
available for patients

new drugs administered to patients in clinical trials

10

articles published on journals of high scientific impact since 2012

20
59

abstracts selected for the main hematology conferences since 2012

news
EMN 2018 Meeting
EMN Meeting – 1st edition – Turin
04/19/2018

Launch of the biennial meeting endorsed by EMN, open to the participation of physicians, biologists and nurses from all around Europe. For the first time, EMN promotes an event open to all the professionals specialized in multiple myeloma and other…

read more >
EMN 2018 - Call for abstracts
Call for abstracts - European Myeloma Network Meeting - Torino 2018
12/15/2017

The abstract submission website for the upcoming European Myeloma Network Meeting (Torino, April 19-21, 2018) is now open: https://emn.abstracts.it/
Abstracts should focus on one of the…

read more >
Under 40 in Hematology
Under 40 in Hematology - Deadline 17-09-2017 - Final Contest Lasize (VR), November 16-17, 2017
11/16/2017

Under 40 in Hematology is a project born in 2012 with the objective to promote scientific contributions and projects of young hematologists. At the core of the initiative, lies the idea of a discussion-based working group of people…

read more >
news